Natus Medical (BABY) Reports In-Line Q1 EPS; Issues Mixed Outlook

Natus Medical (NASDAQ: BABY) reported Q1 EPS of $0.24, in-line with the analyst estimate of $0.24. Revenue for the quarter came in at $128.6 million versus the consensus estimate of $125.98 million.

GUIDANCE:

Natus Medical sees Q2 2018 EPS of $0.25-$0.27, versus the consensus of $0.36. Natus Medical sees Q2 2018 revenue of $129-131 million, versus the consensus of $132.9 million.

Natus Medical sees FY2018 EPS of $1.60-$1.65, versus the consensus of $1.62. Natus Medical sees FY2018 revenue of $535-540 million, versus the consensus of $536.9 million.

For earnings history and earnings-related data on Natus Medical (BABY) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Acurx Pharmaceuticals (ACXP) Tops Q2 EPS by 4c
• Zeo Energy Corp (ZEO) Misses Q2 EPS by 7c